Scott A Foster - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Scott A Foster

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

Cancer Cell|March 22, 2016

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.

Journal of Medicinal Chemistry|April 21, 2009

Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitorsEric E Boros, Cynthia E Edwards, Scott A Foster, et al.

Antimicrobial Agents and Chemotherapy|December 28, 2007

The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviralEdward P Garvey, Brian A Johns, Margaret J Gartland, et al.

Nature Chemical Biology|December 28, 2022

Targeted degradation via direct 26S proteasome recruitmentCharlene Bashore, Sumit Prakash, Matthew C Johnson, et al.

Nature Communications|June 27, 2026

Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer modelThijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.

Pageof 4

Search research articles

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

Cancer Cell|March 22, 2016

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.

Journal of Medicinal Chemistry|April 21, 2009

Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitorsEric E Boros, Cynthia E Edwards, Scott A Foster, et al.

Antimicrobial Agents and Chemotherapy|December 28, 2007

The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviralEdward P Garvey, Brian A Johns, Margaret J Gartland, et al.

Nature Chemical Biology|December 28, 2022

Targeted degradation via direct 26S proteasome recruitmentCharlene Bashore, Sumit Prakash, Matthew C Johnson, et al.

Nature Communications|June 27, 2026

Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer modelThijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.

Pageof 4